FierceBiotech  Apr 24  Comment 
Sanofi is changing its head of global R&D. Elias Zerhouni, M.D., is to retire from the position at the end of June, leaving former Roche research leader John Reed, M.D., Ph.D., to take charge of Sanofi’s pipeline.
FierceBiotech  Apr 23  Comment 
Sanofi is set to lose its global head of diabetes research and translational medicine to Grünenthal. Philip Just Larsen, M.D., Ph.D., will join the German pain specialist at the start of July, leaving Sanofi looking for a diabetes research chief...
FiercePharma  Apr 20  Comment 
WHO advisers changed their recommendations for Sanofi's Dengvaxia, saying it should be used after a diagnostic confirms a prior infection. But as of now, fast and reliable tests don't exist.
FiercePharma  Apr 18  Comment 
Jérôme Contamine, Sanofi's CFO for nearly a decade, plans to step down later this year after a transition period.
FiercePharma  Apr 17  Comment 
The sources were right: Only one day after numerous media reports stated Sanofi was nearing a deal to sell its European generics business to Advent International, the pair admitted they're in exclusive negotiations. And they said Advent plans...
MedPage Today  Apr 16  Comment 
(MedPage Today) -- 13-month advantage in median overall survival
FiercePharma  Apr 16  Comment 
Other bidders may have dropped out of an auction for Sanofi's European generics unit, but that doesn't mean it hasn't found a buyer. The drugmaker is nearing an agreement and could announce a sale in the next several days, Bloomberg reports.
Financial Times  Apr 15  Comment 
Terms being finalised on buyout of European arm some experts value at €2bn
Financial Times  Apr 13  Comment 
Industry experts expect Zentiva to fetch around €2bn
GenEng News  Apr 13  Comment 
Sanofi plans to double its vaccine output by 2023 by building a €350 million ($431.5 million) vaccine manufacturing plant in Toronto. The project underscores the company’s reliance on vaccines as an engine for future growth despite more than...

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki